Suppr超能文献

从半夏中纯化并鉴定一种具有抗肿瘤活性的新型植物凝集素。

Purification and characterization of a novel plant lectin from Pinellia ternata with antineoplastic activity.

作者信息

Zuo Zhenyu, Fan Handong, Wang Xue, Zhou Wei, Li Lingling

机构信息

College of Chemical Engineering and Technology, Wuhan University of Science and Technology, Wuhan, 430081 China.

出版信息

Springerplus. 2012 Aug 16;1:13. doi: 10.1186/2193-1801-1-13. eCollection 2012.

Abstract

A novel Pinellia ternata lectin was purified from the bulbs of a Chinese herb Pinellia ternata using a combination of hydrophobic chromatography and DEAE-ion exchange chromatography. The lectin was found to be a homodimer of 12093.3 Da subunits as determined by gel filtration and MS. Biochemical characterization of the lectin revealed the existence of a glycoprotein, which contains 3.22% neutral sugars. The N-terminal 10-amino acid sequence of the lectin, QGVNISGQVK, has not been reported for other lectins. The lectin had a special agglutinating activity with mouse erythrocytes at a minimum concentration of 8.0 ug/ml. The lectin was stable in the pH range of pH 5-12 and temperatures up to 80°C for 30 min. The results of MTT experiment showed that the lectin had significant effect towards tumor cells, the maximum inhibition of cell proliferation with Sarcoma 180, HeLa and K562 cell line were 85.2%, 74.6% and 59.4% respectively. Experimental therapy in vivo also showed that PTL apparently inhibited transplanted tumor in mice. Flow cytometric analysis demonstrated that PTL inhibited the proliferation of Sarcoma 180 in a time- and dose-dependent manner through inhibiting the transition of G1/S and subsequently inducing G0/G1 cell cycle arrest. Thus, Pinellia ternata lectin displays a high potential for antitumor activity.

摘要

采用疏水层析和DEAE离子交换层析相结合的方法,从中药半夏的鳞茎中纯化出一种新型半夏凝集素。通过凝胶过滤和质谱分析确定,该凝集素是由12093.3 Da亚基组成的同型二聚体。凝集素的生化特性表明其为一种糖蛋白,含有3.22%的中性糖。该凝集素的N端10个氨基酸序列为QGVNISGQVK,尚未见其他凝集素的相关报道。该凝集素对小鼠红细胞具有特殊的凝集活性,最低凝集浓度为8.0 μg/ml。该凝集素在pH 5 - 12范围内以及高达80°C的温度下处理30分钟均保持稳定。MTT实验结果表明,该凝集素对肿瘤细胞具有显著作用,对肉瘤180、HeLa和K562细胞系的细胞增殖抑制率最高分别为85.2%、74.6%和59.4%。体内实验治疗也表明半夏凝集素明显抑制小鼠移植瘤的生长。流式细胞仪分析表明,半夏凝集素通过抑制G1/S期转变并随后诱导G0/G1期细胞周期阻滞,以时间和剂量依赖性方式抑制肉瘤180细胞的增殖。因此,半夏凝集素具有很高的抗肿瘤活性潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验